Expression of inhibin/activin subunits, Sialyl-Lewis A (CA 19-9, sLea) and Sialyl-Lewis X (sLex) carbohydrate antigens in a hydatidiform mole with persistent polymorphic trophoblastic hyperplasia

Anticancer Research

Volumn 25, Issue 3 A, 2005, Pages 1725-1730

  Mylonas, I ^a,d   Makovitzky, J ^b   Vogel, M ^c   Shabani, N ^a   Jeschke, U ^a   Friese, K ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Activin; Gestational trophoblastic disease; Glycodelin; Immunohistochemistry; Inhibin; Invasive mole; Sialyl Lewis A

Indexed keywords

ACTIVIN; CA 19-9 ANTIGEN; CARBOHYDRATE ANTIGEN; INHIBIN; INHIBIN A; INHIBIN B; MONOCLONAL ANTIBODY; SIALYL LEWIS X ANTIGEN;

ADULT; CANCER RISK; CASE REPORT; CHORIOCARCINOMA; CONFERENCE PAPER; CYTOTROPHOBLAST; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MYOMETRIUM; POLYMORPHIC TROPHOBLASTIC HYPERPLASIA; PRIORITY JOURNAL; PROGNOSIS; SYNCYTIOTROPHOBLAST; TROPHOBLASTIC DISEASE;

ACTIVINS; ADULT; CA-19-9 ANTIGEN; FEMALE; HUMANS; HYDATIDIFORM MOLE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INHIBINS; OLIGOSACCHARIDES; PREGNANCY; TROPHOBLASTS;

EID: 21244468696     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W, Sawchenko P et al: Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 44: 1-34, 1988.
2. Ying SY: Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9: 267-293, 1988.
3. de Kretser DM, Hedger MP, Loveland KL and Phillips DJ: Inhibins, activins and follistatin in reproduction. Hum Reprod Update 8: 529-541, 2002.
4. Yohkaichiya T, Fukaya T, Hoshiai H, Yajima A and de Kretser DM: Inhibin: a new circulating marker of hydatidiform mole? BMJ 298: 1684-1686, 1989.
5. Badonnel Y, Barbe F, Legagneur H, Poncelet E and Schweitzer M: Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit. Clin Endocrinol (Oxf) 41: 155-162, 1994.
6. Florio P, Severi FM, Cobellis L, Danero S, Borne A, Luisi S and Petraglia F: Serum activin A and inhibin A. New clinical markers for hydatidiform mole. Cancer 94: 2618-2622, 2002.
7. Kommoss F, Schmidt D, Coerdt W, Olert J and Muntefering H: Immunohistochemical expression analysis of inhibin-alpha and -beta subunits in partial and complete moles, trophoblastic tumors, and endometrial decidua. Int J Gynecol Pathol 20: 380-385, 2001.
8. van Rooijen JJ, Jeschke U, Kamerling JP and Vliegenthart JF: Expression of N-linked sialyl Le(x) determinants and O-glycans in the carbohydrate moiety of human amniotic fluid transferrin during pregnancy. Glycobiology 8: 1053-1064, 1998.
9. Jeschke U, Wang X, Briese V, Friese K and Stahn R: Glycodelin and amniotic fluid transferrin as inhibitors of E-selectin-mediated cell adhesion. Histochem Cell Biol 119: 345-354, 2003.
10. Jeschke U, Stahn R, Goletz C, Wang X, Briese V and Friese K: hCG in trophoblast tumour cells of the cell line Jeg3 and hCG isolated from amniotic fluid and serum of pregnant women carry oligosaccharides of the sialyl Lewis X and sialyl Lewis A type. Anticancer Res 23: 1087-1092, 2003.
11. Chabbert Buffet N, Djakoure C, Maitre SC and Bouchard P: Regulation of the human menstrual cycle. Front Neuroendocrinol 19: 151-186, 1998.
12. Knight PG: Roles of inhibins, activins, and follistatin in the female reproductive system. Front Neuroendocrinol 17: 476-509, 1996.
13. Welt CK: The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. Curr Opin Obstet Gynecol 14: 317-323, 2002.
14. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ and Bradley A: Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 560: 313-319, 1992.
15. Burger HG, Fuller PJ, Chu S, Mamers P, Drummond A, Susil B, Neva P and Robertson DM: The inhibins and ovarian cancer. Mol Cell Endocrinol 180: 145-148, 2001.
16. Garde SV and Sheth AR: Patterns of inhibin and FSH localization in endometrium of baboon (Papio anubis) during menstrual cycle and early pregnancy. Ind J Exp Biol 30: 1006-1011, 1992.
17. Teni TR, Sampat MB and Sheth NA: Inhibin (10.7 kD prostatic peptide) in normal, hyperplastic, and malignant human endometria: an immunohistochemical study. J Pathol 168: 35-40, 1992.
18. Leung PH, Salamonsen LA and Findlay JK: Immunolocalization of inhibin and activin subunits in human endometrium across the menstrual cycle. Hum Reprod 13: 3469-3477, 1998.
19. Otani T, Minami S, Kokawa K, Shikone T, Yamoto M and Nakano R: Immunohistochemical localization of activin A in human endometrial tissues during the menstrual cycle and in early pregnancy. Obstet Gynecol 91: 685-692, 1998.
20. Jones RL, Salamonsen LA, Critchley HO, Rogers PA, Affandi B and Findlay JK: Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception. Mol Hum Reprod 6: 1107-1117, 2000.
21. Mylonas I, Jeschke U, Winkler L, Makovitzky J, Richter DU, Briese V and Friese K: Immunohistochemical expression of inhibin-alpha in human endometrium and the in vitro secretion of inhibin, estradiol and cortisol in cultured human endometrial glandular cells. Arch Gynecol Obstet 268: 142-150, 2003.
22. Mylonas I, Jeschke U, Wiest I, Hoeing A, Vogl J, Shabani N, Kuhn C, Schulze S, Kupka MS, Friese K: Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle. Histochem Cell Biol: 461-471, 2004.
23. Jones RL, Salamonsen LA and Findlay JK: Potential roles for endometrial inhibins, activins and follistatin during human embryo implantation and early pregnancy. Trends Endocrinol Metab 13: 144-150, 2002.
24. Jones RL, Salamonsen LA and Findlay JK: Activin A promotes human endometrial stromal cell decidualization in vitro. J Clin Endocrinol Metab 87: 4001-4004, 2002.
25. Fowler PA, Evans LW, Groome NP, Templeton A and Knight PG: A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy. Hum Reprod 73: 3530-3536, 1998.
26. McCluggage WG, Ashe P, McBride H, Maxwell P and Sloan JM: Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology 32: 252-256, 1998.
27. Pelkey TJ, Frierson HF, Jr, Mills SE and Stoler MH: Detection of the alpha-subunit of inhibin in trophoblastic neoplasia. Hum Pathol 30: 26-31, 1999.
28. Shih IM and Kurman RJ: Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol 18: 144-150, 1999.
29. Pautier P, Ghione S, Brailly-Tabard S, Lhomme C, Morice P and Bidart JM: Are serum inhibin concentrations new markers of placental tumours in the course of chemotherapy? Hum Reprod 16: 2434-2437, 2001.
30. Kato T, Seki K, Matsui H and Sekiya S: Circulating inhibin forms in patients with hydatidiform mole. Gynecol Obstet Invest 54: 114-117, 2002.
31. Vogel M: Atlas der morphologischen Plazentadiagnostik. Springer, 1996.
32. Makovitzky J, Vogel M, Miessner R, Mylonas I, Vogt-Weber B and Richter DU: Diagnostic aspects of hydatidiform mole with persistence of polymorphic trophoblastic hyperplasia. Anticancer Res 23: 1069-1073, 2003.
33. Richter DU, Jeschke U, Makovitzky J, Goletz S, Karsten U, Briese V and Friese K: Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta. Anticancer Res 20: 5129-5133, 2000.
34. Kale A, Soylemez F and Ensari A: Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease. Am J Obstet Gynecol 184: 567-574, 2001.
35. Halperin R, Peller S, Sandbank J, Bukovsky I and Schneider D: Expression of the p53 gene and apoptosis in gestational trophoblastic disease. Placenta 21: 58-62, 2000.
36. Kim YT, Cho NH, Ko JH, Yang WI, Kim JW, Choi EK and Lee SH: Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts. Cancer 89: 673-679, 2000.